Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| ADARx Pharmaceuticals, Inc. (ADRX) | Director | Sep 24, 2026 | Sep 29, 2026 |
Recent filings
The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 28, 2026, ADARx Pharmaceuticals, Inc.: bought 1,600,000 shares for $27.2M; 8,336,661 shares converted (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.